Larvol Delta - A-Study-to-Evaluate-the-Safety-and-Tolerability-of-ETC1922159-as-a-Single-Agent-and-in-Combination-With-Pembrolizumab-in-Advanced-Solid-Tumours

ETC159 - Experimental Therapeutics Centre

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT02521844

Dec 15, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next